Apertus Pharmaceuticals
St Louis
About Apertus Pharmaceuticals
Apertus Pharmaceuticals is an Active Pharmaceutical Ingredient, or API, manufacturing company targeting dosage form manufacturing companies within the pharmaceutical industry. Apertus Pharmaceuticals provides controlled substance APIs, non controlled substance APIs, and intellectual property to the pharmaceutical market. In addition, Apertus Pharmaceuticals utilizes the philosophies of Green Chemistry as outlined by the FDA and will target higher purity standards than those set by the current standard setting authorities. Apertus is led by CEO Rick Ryan, Ph.D. and CSO David Gindelberger, Ph.D.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $700.0K
- Last round: Grant (Jan 2012)
- Website: apertuspharma.com
- Phone: 866.576.2746
Industries & Categories
Biotechnology, Developer APIs, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/apertus-pharmaceuticals-2432041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.